Open AccessThe use of calcium gluconate priorto verapamil in infants with paroxysmal supraventricular tachycardia
Author(s) -
Roguin N.,
Shapir Y.,
Blazer S.,
Zeltzer M.,
Berant M.
Publication year - 1984
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960071112
Subject(s) - verapamil , medicine , supraventricular tachycardia , paroxysmal supraventricular tachycardia , tachycardia , sinus rhythm , calcium , cardiology , anesthesia , inotrope , atrial fibrillation
Verapamil is a useful drug for treating supraventricular tachycardia; however, severe side effects occasionally have been reported in infants. We describe here our experience with the use of a 10 percent solution of intravenous calcium gluconate prior to the use of verapamil in infants with paroxysmal supraventricular tachycardia. In all the attacks verapamil converted the supraventricular tachycardia to sinus rhythm. We feel that calcium gluconate injected previous to verapamil can avoid the negative inotropic effects without interfering with the antiarrhythmic properties of verapamil.